A Phase II, Randomized, Double Blind, Placebo Controlled Study Evaluating the Treatment of Degenerative Lumbar Discs With Allogeneic Cultured Chondrocytes
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2017
Price : $35 *
At a glance
- Drugs Homologous chondrocytes (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Isto Biologics
- 07 Sep 2016 Planned End Date changed from 1 Jun 2018 to 1 Sep 2016.
- 07 Sep 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2016.
- 07 Sep 2016 Status changed from active, no longer recruiting to discontinued.